期刊文献+

合成生物学时代的生物安全治理 被引量:5

Biosafety and Biosecurity Governance in the Era of Synthetic Biology
下载PDF
导出
摘要 20世纪中后期,基因重组技术的产生及其在遗传育种等领域的应用,结合致病性微生物实验室研究安全问题的显现,不仅引发了科技界对生物安全问题的关注,也推动了系列管理规范与措施的建立。21世纪以来,合成生物学的发展为资源、能源、健康、环境等领域带来了全新的解决方案,但因其技术、研发与应用存在生物安全相关的不确定性风险,给生物安全治理带来了新挑战。本文在梳理生物安全/安保的概念、相应的监管政策制定及演变的基础上,对合成生物学时代的生物安全风险的成因、治理策略进行探讨,并为我国生物安全治理体系的建设提供建议。 In the second half of the 20th century,the development of gene recombination technology and its application in genetic breeding and other fields,combined with the emergence of safety issues associated with pathogenic microbial research laboratory,not only have caught the attention of the scientific community to biosafety,but also promoted the establishment of a series of biorisk measures and management system.Since the 21st century,the development of synthetic biology has brought new solutions to the fields of resources,energy,health,and the environment.However,the uncertain risks associated with biosafety/biosecurity in its technology,products and applications have brought new challenges to biosafety and biosecurity governance.On the basis of sorting out the formation and evolution of biosafety/biosecurity concepts and corresponding regulatory policies,this article discusses the underlying causes and governance strategies of biosafety/biosecurity risks in synthetic biology,and provides practical for the construction of biosafety and biosecurity governance system in China.
作者 刘晓 汪哲 陈大明 熊燕 赵国屏 LIU Xiao;WANG Zhe;CHEN Da-ming;XIONG Yan;ZHAO Guo-ping(Shanghai Institute of Nutrition and Health,Chinese Academy of Sciences;University of Chinese Academy of Sciences;Center for Excellence in Molecular Plant Science,Chinese Academy of Sciences)
出处 《科学与社会》 CSSCI 2022年第3期1-14,共14页 Science and Society
基金 国家重点研发计划“合成生物学”重点专项“合成生物学生物安全研究”(2020YFA0908600) 国家自然科学基金(NFSC)-中国科学院(CAS)联合项目“合成生物学发展战略研究(2021-2035)”(XK2019SMA002)。
关键词 合成生物学 生物安全 生物安保 治理策略 synthetic biology biosafety biosecurity governance strategies
  • 相关文献

参考文献11

二级参考文献79

  • 1Bhattacharjee Y(2007)Gene-synthesis companies join forces to self-regulate.Science,316,1682.
  • 2Cello J,Paul AV,Wimmer E(2002)Chemical synthesis of poliovirus cDNA:generation of infectious virus in the ab-sence of natural template.Science,297,1016-1018.
  • 3Elowitz MB,Leibler S(2000)A synthetic oscillatory network of transcriptional regulators.Nature,403,335-338.
  • 4Gardner TS,Cantor CR,Collins JJ(2000)Construction of a genetic toggle switch in Escherichia coli.Nature,403,339-342.
  • 5Heller MA,Eisenberg RS(1998)Can patents deter innovation?The anticommons in biomedical research.Science,280,698-701.
  • 6Kaiser J(2007)Synthetic biology:attempt to patent artificial organism draws a protest.Science,316,1557.
  • 7O’Malley M,Powell A,Davies JF,Calvert J(2008)Know-ledgemaking distinctions in synthetic biology.BioEssays,30,57-65.
  • 8Ro D-K,Paradise EM,Ouellet M,Fisher KJ,Newman KL,Ndungu JM,Ho KA,Eachus RA,Ham TS,Kirby J,Chang MCY,Withers ST,Shiba Y,Sarpong R,Keasling JD(2006)Production of the antimalarial drug precursor artemisinic acid in engineered yeast.Nature,440,940-943.
  • 9Schmidt M(2006)Public will fear biological accidents,not just attacks.Nature,441,1048.
  • 10Priska Gisler,Monika Kurath. Paradise Lost? "Science" and "the Public" after Asilomar[J].Science Technology & Human Values,2011,(02):213-243.

共引文献97

同被引文献40

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部